IDP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biogen Inc

Watchlist Manager

Watchlist

Price: 169.76 EUR 2.13%

Market Cap: €24.7B

B	Biogen Inc XHAM:IDP	US
F	Ferrari NV F:2FE	IT
C	CNA Financial Corp F:CNH	US
	Invesco Ltd NYSE:IVZ	US
Z	Zevra Therapeutics Inc F:1GDA	US
	UBS Group AG SIX:UBSG	CH
F	FedEx Freight Holding Company Inc NYSE:FDXF	US
	Contemporary Amperex Technology Co Ltd F:C7A0	CN
H	Hawesko Holding AG XHAM:HAW	DE
	Yankuang Energy Group Co Ltd SSE:600188	CN

Profitability Summary

Biogen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

76%

Declining Gross Margin

77% > 75%

Healthy Operating Margin

26%

Sustainable 3Y Average Operating Margin

26%

Declining Operating Margin

30% > 26%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

15%

Declining Net Margin

27% > 14%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

18%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.